37 research outputs found
Novel study designs to investigate the placebo response
<p>Abstract</p> <p>Background</p> <p>Investigating the size and mechanisms of the placebo response in clinical trials have relied on experimental procedures that simulate the double-blind randomized placebo-controlled design. However, as the conventional design is thought to elucidate drug rather than placebo actions, different methodological procedures are needed for the placebo response.</p> <p>Methods</p> <p>We reviewed the respective literature for trials designs that may be used to elucidate the size of the placebo response and the mechanisms associated with it.</p> <p>Results</p> <p>In general, this can be done by either manipulation the information provided to the subjects, or by manipulation the timing of the drug applied. Two examples of each strategy are discussed: the "balanced placebo design" (BDP) and the "balanced cross-over design" (BCD) and their variants are based on false information, while the "hidden treatment" (HT) and the ""delayed response test" (DRT) are based on manipulating the time of drug action. Since most such approaches include deception or incomplete information of the subjects they are suitable for patient only with authorized deception.</p> <p>Conclusion</p> <p>Both manipulating the information provided to subjects (BDP, DCD) or manipulating the timing of drug application (HT, DRT) allows overcoming some of the restrictions of conventional drug trials in the assessment of the placebo response, but they are feasible mostly in healthy subjects for ethical reasons.</p
Efficacy and Safety of a Traditional Herbal Combination in Patients with Type II Diabetes Mellitus: A Randomized Controlled Trial
Headspace solid-phase microextraction of menthol using a sol–gel titania-based coating along with multiwalled carbon nanotubes on the surface of stainless steel fiber
Improving waste incineration CHP plant efficiency by waste heat recovery for feedwater preheating process: energy, exergy, and economic (3E) analysis
A Modeling the Supplier Relationship Management in Agribusiness Supply Chain
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial.This research analyzes the current studies of supplier relationship management (SRM), based on a literature review to contrast and compare the evolution of SRM in agribusiness-oriented supply chain management (SCM). The result obtained in this research shows the agribusiness and its relationship with its suppliers. It also strives to identify potential models for a strong SRM. An SRM model is proposed to visualize the components that make up the management of suppliers in the agribusiness supply chain (SC)
Development and evaluation of Cetirizine HCl taste-masked oral disintegrating tablets
The purpose of the current study was to mask the taste of cetirizine HCl and to incorporate the granules produced in oral disintegrating tablets (ODT). The bitter, active substance was coated by fluidized bed coating using Eudragit® RL30-D at levels between 15% and 40% w/w. The ODTs were developed by varying the ratio of superdisintegrants such as sodium croscarmellose, crospovidone grades and low substituted hydroxypropyl cellulose (L-HPC). A direct compression process was used to compress the ODTs under various compaction forces to optimize tablet robustness. The properties of the compressed tablets including porosity, hardness, friability and dissolution profiles were further investigated. The in vitro and in vivo evaluation of the tablet disintegration times showed almost identical rapid disintegration below 10 s at the optimal levels of each superdisintegrant. Finally, the taste and sensory evaluation in human volunteers demonstrated excellence in masking the bitter active and tablet palatability